Last reviewed · How we verify
NCT04400409
Implementation of Vascular Care Team to Improve Medical Management of PAD Patients
NA trial testing Intervention A - Vascular Care + site 6MWT administration in Peripheral Artery Disease in 166 participants. Completed in 11 May 2023.
11 May 2023
Quick facts
| Lead sponsor | Colorado Prevention Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 166 |
| Start date | 7 July 2020 |
| Primary completion | 11 May 2023 |
| Estimated completion | 11 May 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Intervention A - Vascular Care + site 6MWT administration
- Intervention B - Standard Care + site 6MWT administration
- Intervention A - Vascular Care + CPC EQuIP 6MWT administration
- Intervention B - Standard Care + CPC EQuIP 6MWT administration
Conditions studied
- Peripheral Artery Disease — all drugs for Peripheral Artery Disease →
Sponsor
Colorado Prevention Center
Who can join
Eligibility, any sex, with Peripheral Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study intends to evaluate the efficacy of a multidisciplinary vascular care team utilizing an intensive guideline-based lipid reduction program in improving risk factor modification as measured by LDL-C reduction at 12 months in patients with peripheral artery disease (PAD). An additional objective is to understand the potential reach and impact if this program were extended across the University of Colorado Healthcare (UC Health) System.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Management of Peripheral Arterial Disease: Lifestyle Modifications and Medical Therapies.
King RW, Canonico ME, Bonaca MP, Hess CN. · · 2022 · cited 15× · PMID 39132343 · DOI 10.1016/j.jscai.2022.100513
Verify or expand the search:
- PubMed search for NCT04400409
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peripheral Artery Disease
Currently open trials in the same condition.
- NCT07374601 — The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease · recruiting
- NCT06686121 — Improving Mobility After Revascularization in Peripheral Artery Disease · Phase 3 · recruiting
- NCT04433572 — Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee · Phase 3 · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT07012070 — Improving Walking Performance in Patients With Peripheral Artery Disease Through Wearable Activity Trackers · NA · recruiting
Other Colorado Prevention Center trials
Trials by the same sponsor.
- NCT04807218 — Virta Intervention in CommuniTies in cOloRado (VICTOR-Pilot) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04400409 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Colorado Prevention Center
- Last refreshed: 8 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04400409.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing